Citation Tools
PDFImmunotherapy biomarkers
Original research
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab